UBS AM’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $905K | Sell |
19,164
-24,640
| -56% | -$1.16M | ﹤0.01% | 2409 |
|
|
2025
Q1 | $1.71M | Buy |
43,804
+1,568
| +4% | +$61.3K | ﹤0.01% | 2068 |
|
|
2024
Q4 | $2.29M | Buy |
42,236
+6,422
| +18% | +$348K | ﹤0.01% | 1971 |
|
|
2024
Q3 | $1.81M | Buy |
35,814
+17,580
| +96% | +$886K | ﹤0.01% | 2086 |
|
|
2024
Q2 | $802K | Buy |
18,234
+3,003
| +20% | +$132K | ﹤0.01% | 2471 |
|
|
2024
Q1 | $765K | Hold |
15,231
| – | – | ﹤0.01% | 2145 |
|
|
2023
Q4 | $920K | Buy |
15,231
+53
| +0.3% | +$3.2K | ﹤0.01% | 2070 |
|
|
2023
Q3 | $865K | Buy |
+15,178
| New | +$865K | ﹤0.01% | 2030 |
|